Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Interleukin-17A in Egyptian leprosy patients: a clinical, genetic, and biochemical study
Azza Gaber Antar Faraga,
Corresponding author
azzagaber92@yahoo.com

Corresponding author.
, Azza Zagloul Labeebb, Amany Nagy Abdalla Gergesc, Mustafa Elsayed Elshaibd
a Dermatology, Andrology and STDs Department, Faculty of Medicine, Menoufia University, Egypt
b Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Egypt
c Leprosy and Dermatology Clinic, Ministry of Health, Shebin Elkoom Teaching Hospital, Egypt
d Medical Student, Faculty of Medicine, Menoufia University, Egypt
Read
2751
Times
was read the article
1113
Total PDF
1638
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 10 12 22
2024 April 97 78 175
2024 March 88 65 153
2024 February 84 91 175
2024 January 81 52 133
2023 December 81 62 143
2023 November 102 84 186
2023 October 82 76 158
2023 September 77 72 149
2023 August 48 30 78
2023 July 52 33 85
2023 June 58 45 103
2023 May 53 32 85
2023 April 36 18 54
2023 March 78 38 116
2023 February 110 36 146
2023 January 59 48 107
2022 December 178 61 239
2022 November 133 79 212
2022 October 112 76 188
2022 September 19 25 44
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.